https://orcid.org/0000-0002-5924-4953
References
- Chen Y, Sun J, Yang Y, et al. Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses. Clin Rheumatol. 2016;35(1):1–18.
- Colombel JF, Sandborn WJ, Reinisch W, et al. Long-term safety of adalimumab in clinical trials in adult patients with Crohn’s disease or ulcerative colitis. Aliment Pharmacol Ther. 2018;47(2):219–228.
- Magro F, Soares JB, Fernandes D. Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World J Gastroenterol. 2014;20(17):4857–4872.
- Giannotta M, Tapete G, Emmi G, et al. Thrombosis in inflammatory bowel diseases: what’s the link? Thromb J. 2015;13:14.
- Alkim H, Koksal AR, Boga S, et al. Prevention, and treatment of thromboembolism in inflammatory bowel disease. Clin Appl Thromb Hemost. 2017;23(6):501–510.
- Andrade AR, Barros LL, Azevedo MFC, et al. Risk of thrombosis and mortality in inflammatory bowel disease. Clin Transl Gastroenterol. 2018;9(4):142.
- Nguyen GC, Bernstein CN, Bitton A, et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian association of gastroenterology. Gastroenterology. 2014;146(3):835–48 e6.
- Lobo JL, Garcia-Fuertes JA, Trujillo-Santos J, et al. Anticoagulant therapy for venous thromboembolism in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2018;30(5):526–530.
- Koutroumpakis EI, Tsiolakidou G, Koutroubakis IE. Risk of venous thromboembolism in patients with inflammatory bowel disease. Semin Thromb Hemost. 2013;39(5):461–468.
- Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism. World J Gastroenterol. 2014;20(38):13863–13878.
- Bryant RV, Jairath V, Curry N, et al. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk? J Crohns Colitis. 2014;8(2):166–171.
- Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375(9715):657–663.
- Kim S-HSJ, Sung Y, Park JK, et al. Use of novel oral anticoagulant to treat pulmonary thromboembolism in patient with ulcerative colitis superinfected cytomegalovirus colitis. Korean J Gastroenterol. 2017;70(1):44–49.